 |
| Send E-mail to: ztokes@usc.edu | | | Telephone: 323-224-7775 | Fax: 323-224-7679 | | Office: CRL 102 | Mail Code: 9270 HSC |
Education: PhD 1970 - California Institute of Technology
Research Topics: Developmental Biology, Cell Cycle, Growth & Proliferation, Signal Transduction
Research Description Investigations in our laboratory focus on two converging topics. First, we want to study the dynamic events which are involved in the maintenance and remodeling of three-dimensional cellular networks. Second, we want to find new methods by which to deliver biologically active compounds into specific tissue compartments to re-establish regular tissue architecture. A gradual breakdown of tissue structures occurs during the progressive growth of cancer. Profound synaptic rearrangements take place during memory consolidation in the central nervous system, and a striking destruction of tissue architecture is observed in the brain with aging, especially in patients with AlzheimerŐs disease. Our research focuses on proteinases and their inhibitors since all of these events are influenced by their availability. Both metastatic cancer cells and invading nerve growth cones use matrix metalloproteinases, MMPs, capable of degrading tissue matrix components. We discovered that hippocampal neurons from Alzheimer patients express high amounts of inactive MMPs, and hypothesize that their activation may be blocked by excess inhibitors. Of interest is our observation that activated MMPs are capable of degrading amyloid peptides which would otherwise accumulate in the brain as insoluble deposits in the senile plaques. This finding also suggests that the activation of MMPs would result in more efficient destruction of amyloid peptides and reduce their accumulation in senile plaques. Consequently, the delivery of activating agents, or other biologically relevant compounds, to the brain may have therapeutic significance. Quantitation of MMP-produced fragments in the spinal fluid may provide diagnostic information. The possibility that measurement of MMP-produced amyloid fragments in the spinal fluid may provide diagnostic information is under investigation. In situ hybridization with RNA-probe for MMP shows their synthesis in hippocampal neurons of AlzheimerŐs patients. Immunohistochemistry shows the accumulation of protease inhibitor, alpha-1-antichymotrypsin, in the same neurons.
10 Selected Publications:
Click here to view all the publications for this faculty
Lim GP,Russell MJ,Cullen MJ,Tökés ZA - Matrix metalloproteinases in dog brains exhibiting Alzheimer-like characteristics. - J Neurochem [1997] Apr;68(4):1606-11 PubMed
Backstrom JR,Lim GP,Cullen MJ,Tökés ZA - Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40). - J Neurosci [1996] Dec 15;16(24):7910-9 PubMed
Lim GP,Backstrom JR,Cullen MJ,Miller CA,Atkinson RD,Tökés ZA - Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients. - J Neurochem [1996] Jul;67(1):251-9 PubMed
Backstrom JR,Tökés ZA - The 84-kDa form of human matrix metalloproteinase-9 degrades substance P and gelatin. - J Neurochem [1995] Mar;64(3):1312-8 PubMed
Neri A,Bohoslawec O,Anderson TD,Tokes ZA - Differential release of active proteinase inhibitors by two rat mammary adenocarcinoma variants possessing different metastatic potentials. - Cancer Res [1991] Feb 15;51(4):1318-25 PubMed
Backstrom JR,Miller CA,Tökés ZA - Characterization of neutral proteinases from Alzheimer-affected and control brain specimens: identification of calcium-dependent metalloproteinases from the hippocampus. - J Neurochem [1992] Mar;58(3):983-92 PubMed
DeLeve LD,Wang X,Kanel GC,Ito Y,Bethea NW,McCuskey MK,Tokes ZA,Tsai J,McCuskey RS - Decreased hepatic nitric oxide production contributes to the development of rat sinusoidal obstruction syndrome. - Hepatology [2003] Oct;38(4):900-8 PubMed
Deleve LD,Wang X,Tsai J,Kanel G,Strasberg S,Tokes ZA - Sinusoidal obstruction syndrome (veno-occlusive disease) in the rat is prevented by matrix metalloproteinase inhibition. - Gastroenterology [2003] Sep;125(3):882-90 PubMed
Ren S,Tokes ZA,Csipke C,Zhou B,Yen Y,Lien EJ - Inhibition of tumor cell growth by Schiff bases of hydroxysemicarbazide. - Anticancer Res [2001] Sep-Oct;21(5):3445-51 PubMed
Ren S,Wang R,Komatsu K,Bonaz-Krause P,Zyrianov Y,McKenna CE,Csipke C,Tokes ZA,Lien EJ - Synthesis, biological evaluation, and quantitative structure-activity relationship analysis of new Schiff bases of hydroxysemicarbazide as potential antitumor agents. - J Med Chem [2002] Jan 17;45(2):410-9 PubMed
| |
NCBI Disclaimers and copyright notice
Last updated: Monday August 10th 10:10am 2009 Return to PIBBS home page | Research Topics page
|